<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18167">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01710410</url>
  </required_header>
  <id_info>
    <org_study_id>#006/2012-01</org_study_id>
    <nct_id>NCT01710410</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation in a Smoking Cessation Trial</brief_title>
  <acronym>tDCS</acronym>
  <official_title>Pilot Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment in a Validated Smoking Cessation Protocol for Nicotine Dependent Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre for Addiction and Mental Health</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether transcranial direct current stimulation
      (tDCS) is an effective add-on treatment in a validated smoking cessation protocol for
      nicotine dependent smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:  Transcranial direct current stimulation (tDCS) is a form of non-invasive brain
      stimulation that involves the application of brief  weak electric current to the scalp. tDCS
      may induce neuroplasticity, thereby engaging some of the same systems that figure
      prominently in the pathological neuroplasticity caused by addictive drugs.

      OBJECTIVE:  To assess whether tDCS delivered in addition to standard smoking cessation
      treatment (cognitive behavioural therapy and nicotine patch) reliably increases quit rates.

      METHOD:  Active (20min; 2mA) and sham (30sec; 2mA) stimulation will be applied to the
      dorsolateral prefrontal cortex (DLPFC) and orbitofrontal cortex (OFC) in both cerebral
      hemispheres.

      HYPOTHESES:

        1. Active tDCS (20-min; 2 mA) will increase abstinence in a standard smoking cessation
           protocol relative to a sham procedure when combined with cognitive-behavioural group
           therapy plus nicotine patch.

        2. The benefits of active tDCS to the OFC (anode-left/cathode-right) will be greater than
           the (anode-left/cathode-right)DLPFC configuration.

        3. The benefits of active tDCS (anode-left/cathode-right) to the OFC and to the DLPFC will
           be greater than of active tDCS in the reverse configuration (cathode-left/anode-right)
           to the respective regions.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Funding
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Smoking Cessation</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of one year.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure whether active tDCS increases abstinence in a standard smoking cessation protocol relative to a sham tDCS procedure when combined with cognitive-behavioural group therapy plus nicotine patch.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation rate following transcranial direct current stimulation applied to the dorsolateral prefrontal cortex or orbitofrontal cortex.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of one year.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure whether the benefits of active tDCS to the OFC (anode-left/cathode-right) is greater than the conventional configuration (anode-left/cathode-right) to the DLPFC.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Smoking cessation rate following transcranial direct current stimulation applied to the left dorsolateral prefrontal cortex and orbitofrontal cortex versus the right dorsolateral prefrontal cortex and orbitofrontal cortex.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of one year.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure whether the benefits of active tDCS (anode-left/cathode-right) to the OFC and to the DLPFC will be greater than of active tDCS in the reverse configuration (cathode-left/anode-right) to the respective regions.</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>DLPFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the left DLPFC. Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DLPFC tDCS (left cathode/right anode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the right DLPFC.  Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the left OFC.  Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFC tDCS (left cathode/right anode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the right OFC.  Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DLPFC tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial Direct Current Stimulation (tDCS) delivered to the DLPFC.  Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFC tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial Direct Current Stimulation (tDCS) delivered to the OFC.  Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active transcranial Direct Current Stimulation</intervention_name>
    <description>Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
    <arm_group_label>DLPFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_label>DLPFC tDCS (left cathode/right anode)</arm_group_label>
    <arm_group_label>OFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_label>OFC tDCS (left cathode/right anode)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham transcranial Direct Current Stimulation</intervention_name>
    <description>Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.</description>
    <arm_group_label>DLPFC tDCS</arm_group_label>
    <arm_group_label>OFC tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  nicotine dependent

          -  treatment-seeking

          -  smoke minimum of 15 cigarettes per day

          -  able to provide written informed consent

          -  able and willing to attend weekly appointments, inter-treatment and follow-up
             assessment

          -  able and willing to wear nicotine patch

        Exclusion Criteria:

          -  currently taking GABA receptor agonists, NMDA receptor antagonists, dopamine receptor
             agonists/antagonists, SSRIs, L-dopa, anticholinergics

          -  pregnancy or lactation

          -  any serious medical condition requiring treatment or medication including high blood
             pressure, heart problems, asthma, epilepsy

          -  brain/neurological injury/disease/disorder

          -  skin disease

          -  current DSM-IV Axis I psychiatric disorder

          -  metal or medical device implants

          -  current treatment for alcohol or drug use

          -  current use of herbal/holistic preparations

          -  current use of recreational drugs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Zack, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Addiction and Mental Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health (Nicotine Dependence Clinic)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 1P5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.camh.ca</url>
    <description>Centre for Addiction and Mental Health (investigator-driven, not initiated, study)</description>
  </link>
  <link>
    <url>http://www.braininstitute.ca/</url>
    <description>Ontario Brain Institute</description>
  </link>
  <link>
    <url>http://www.ivhdl.com/ctms/controllers/index.php</url>
    <description>NorDocs Technologies Inc. (regulatory sponsor with Health Canada)</description>
  </link>
  <reference>
    <citation>Boggio PS, Liguori P, Sultani N, Rezende L, Fecteau S, Fregni F. Cumulative priming effects of cortical stimulation on smoking cue-induced craving. Neurosci Lett. 2009 Sep 29;463(1):82-6. Epub 2009 Jul 18.</citation>
    <PMID>19619607</PMID>
  </reference>
  <reference>
    <citation>Feil J, Zangen A. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav Rev. 2010 Mar;34(4):559-74. Epub 2009 Nov 13. Review.</citation>
    <PMID>19914283</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Liguori P, Fecteau S, Nitsche MA, Pascual-Leone A, Boggio PS. Cortical stimulation of the prefrontal cortex with transcranial direct current stimulation reduces cue-provoked smoking craving: a randomized, sham-controlled study. J Clin Psychiatry. 2008 Jan;69(1):32-40.</citation>
    <PMID>18312035</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>September 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre for Addiction and Mental Health</investigator_affiliation>
    <investigator_full_name>Martin Zack</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>transcranial Direct Current Stimulation</keyword>
  <keyword>nicotine dependence</keyword>
  <keyword>dorsolateral prefrontal cortex</keyword>
  <keyword>orbitofrontal cortex</keyword>
  <keyword>cognitive behavioural therapy</keyword>
  <keyword>nicotine replacement therapy</keyword>
  <keyword>nicotine patch</keyword>
  <keyword>addiction</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>neuroplasticity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
    <mesh_term>Smoking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
